论文部分内容阅读
TA-077[研制单位]田边制药[研究阶段]Ⅲ期临床[用途]抗癌药[剂型]口服剂[专利]GB 2002370;GB2053918;JP K 79 103826;JP K 80 31031;US4182
TA-077 [research and development unit] Tanabe Pharma [research phase] Phase III clinical [usage] anticancer drug [dosage form] oral [GB] Patent No. GB313370; GB2053918; JP K79 103826; JP K8031031; US4182